HCW Biologics Inc.HB
SEC Form D filing

HCW Biologics Inc.

Biotech · Series A · Regulation D 506(b) · FL · Filed June 8, 2026

Offering amount
$4.0M
Exemption
Reg D 506(b)
Issuer state
FL
Filing date
June 8, 2026
Signature date
June 8, 2026
CIK
0001828673

Summary

Auto-generated

biotechnology company developing immunotherapies, $4.0M series-a in FL

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.